* The conversation also tackles testosterone therapy in men with prostate cancer, a complex and sometimes controversial issue. Gonzalgo emphasizes individualized decisions, noting that for men with lower- to intermediate-risk disease, continuing therapy may be reasonable. Both physicians stress...
In this episode, Dr. Morgentaler talks about how low testosterone—not high—might actually be the real risk factor for prostate cancer, challenging decades of outdated beliefs.
00:28 – Historical Beliefs and Misconceptions
For decades, doctors thought testosterone fueled prostate cancer like...
Is testosterone truly the villain in prostate cancer, or have we been misled for decades? In this episode of Optimized Health, Josh Porter sits down with world-renowned urologist and testosterone researcher Dr. Abraham Morgentaler to unravel one of the most persistent myths in medicine. They...